Abstract
Although many efforts have been made to investigate a promising biomarker for the diagnosis of papillary thyroid cancer (PTC), the currently available biomarkers lack the sensitivity to accurately characterize PTC. Here, we established a high-sensitivityt cell-free DNA (cfDNA) detection system using polydopamine-silica (PDA/SiO2) hybrids to enable clinically reliable analysis of PTC. The PDA/SiO2-coated beads improved the detection of DNA by 1.76-fold (p=0.031) compared to the conventional silica-based cfDNA capture system. The PDA-SiO2-coated beads were then applied for the detection of cfDNA from serum samples obtained from 37 PTC patients, and the BRAFV600E mutation status in captured DNA was analyzed using both quantitative polymerase chain reaction (qPCR) and digital droplet PCR (ddPCR). The BRAFV600E mutation status analyzed using both assays demonstrated a strong correlation with the multifocality of PTC, exhibiting area under receiver operating characteristic curve (AUC-ROC) of >0.964 (p<0.001). In contrast, none of the serum antigens or antibodies related to PTC or thyroid functions exhibited clinically significant prediction for detecting PTC patients with multifocal tumors. These findings suggest that cfDNA capture using PDA/SiO2-coated beads is a promising approach for analyzing the BRAF mutation, which can serve as an excellent diagnostic biomarker for PTC.
Similar content being viewed by others
References
A. Miranda-Filho, J. Lortet-Tieulent, F. Bray, B. Cao, S. Franceschi, S. Vaccarella and L. Dal Maso, Lancet Diabetes Endocrinol., 9(4), 225 (2021)
J. Ferlay, M. Colombet, I. Soerjomataram, D. M. Parkin, M. Piñeros, A. Znaor and F. Bray, Int. J. Cancer, Online ahead of print (2021).
B. R. Haugen, E. K. Alexander, K. C. Bible, G. M. Doherty, S. J. Mandel, Y. E. Nikiforov, F. Pacini, G. W. Randolph, A. M. Sawka, M. Schlumberger, K. G. Schuff, S. I. Sherman, J. A. Sosa, D. L. Steward, R. M. Tuttle and L. Wartofsky, Thyroid, 26(1), 1 (2016)
A. Prete, P. Borges de Souza, S. Censi, M. Muzza, N. Nucci and M. Sponziello, Front. Endocrinol., 11, 102 (2020).
M. Xing, W. H. Westra, R. P. Tufano, Y. Cohen, E. Rosenbaum, K. J. Rhoden, K. A. Carson, V. Vasko, A. Larin, G. Tallini, S. Tolaney, E. H. Holt, P. Hui, C. B. Umbricht, S. Basaria, M. Ewertz, A. P. Tufaro, J. A. Califano, M. D. Ringel, M. A. Zeiger, D. Sidransky and P. W. Ladenson, J. Clin. Endocrinol. Metab., 90(12), 6373 (2005).
M. Xing, A. S. Alzahrani, K. A. Carson, Y. K. Shong, T. Y. Kim, D. Viola, R. Elisei, B. Bendlová, L. Yip, C. Mian, F. Vianello, R. M. Tuttle, E. Robenshtok, J. A. Fagin, E. Puxeddu, L. Fugazzola, A. Czarniecka, B. Jarzab, C. J. O’Neill, M. S. Sywak, A. K. Lam, G. Riesco-Eizaguirre, P. Santisteban, H. Nakayama, R. Clifton-Bligh, G. Tallini, E. H. Holt and V. Sýkorová, J. Clin. Oncol., 33(1), 42 (2015).
M. Xing, A. S. Alzahrani, K. A. Carson, D. Viola, R. Elisei, B. Bendlova, L. Yip, C. Mian, F. Vianello, R. M. Tuttle, E. Robenshtok, J. A. Fagin, E. Puxeddu, L. Fugazzola, A. Czarniecka, B. Jarzab, C. J. O’Neill, M. S. Sywak, A. K. Lam, G. Riesco-Eizaguirre, P. Santisteban, H. Nakayama, R. P. Tufano, S. I. Pai, M. A. Zeiger, W. H. Westra, D. P. Clark, R. Clifton-Bligh, D. Sidransky, P. W. Ladenson and V. Sykorova, Jama, 309(14), 1493 (2013).
J. Ge, J. Wang, H. Wang, X. Jiang, Q. Liao, Q. Gong, Y. Mo, X. Li, G. Li, W. Xiong, J. Zhao, Z. Zeng and J. Ge, J. Cancer, 11(4), 932 (2020).
R. Elisei, D. Viola, L. Torregrossa, R. Giannini, C. Romei, C. Ugolini, E. Molinaro, L. Agate, A. Biagini, C. Lupi, L. Valerio, G. Materazzi, P. Miccoli, P. Piaggi, A. Pinchera, P. Vitti and F. Basolo, J. Clin. Endocrinol. Metab., 97(12), 4390 (2012).
M. Mekel, H. Gilshtein, A. Al-Kurd, B. Bishara, M. M. Krausz, H. R. Freund, Y. Kluger, A. Eid and H. Mazeh, World J. Surg., 40(1), 124 (2016).
S. R. Orell, Cytopathology, 14(4), 173 (2003).
R. Abi-Raad, M. Prasad, R. Baldassari, K. Schofield, G. G. Callender, D. Chhieng and A. J. Adeniran, Endocr. Pathol., 29(3), 269 (2018).
X. M. Yu, P. N. Patel, H. Chen and R. S. Sippel, Am. J. Surg., 203(3), 331 (2012).
M. J. Campbell, C. D. Seib, L. Candell, J. E. Gosnell, Q. Y. Duh, O. H. Clark and W. T. Shen, World J. Surg., 39(3), 695 (2015).
A. Finkel, L. Liba L, E. Simon, T. Bick, E. Prinz, E. Sabo, O. Ben-Izhak and D. Hershkovitz, J. Clin. Endocrinol. Metab., 101(4), 1407 (2016).
A. Guerra, M. R. Sapio, V. Marotta, E. Campanile, S. Rossi, I. Forno, L. Fugazzola, A. Budillon, T. Moccia, G. Fenzi and M. Vitale, J. Clin. Endocrinol. Metab., 97(2), 517 (2012).
C. Pupilli, P. Pinzani, F. Salvianti, B. Fibbi, M. Rossi, L. Petrone, G. Perigli, M. L. De Feo, V. Vezzosi, M. Pazzagli, C. Orlando and G. Forti, J. Clin. Endocrinol. Metab., 98(8), 3359 (2013).
K. Jensen, S. Thakur, A. Patel, M. C. Mendonca-Torres, J. Costello, C. J. Gomes-Lima, M. Walter, L. Wartofsky, K. D. Burman, A. Bikas, D. Ylli, V. V. Vasko and J. Klubo-Gwiezdzinska, J. Clin. Med., 9(8), 2481 (2020).
B. H. Kim, I. J. Kim, B. J. Lee, J. C. Lee, I. S. Kim, S. J. Kim, W. J. Kim, Y. K. Jeon, S. S. Kim and Y. K. Kim, Yonsei Med. J., 56(3), 634 (2015).
T. Lee, P. A. Rawding, J. Bu, S. Hyun, W. Rou, H. Jeon, S. Kim, B. Lee, L. J. Kubiatowicz, D. Kim, S. Hong and H. Eun, Cancers, 14(9), 2061 (2022).
J. Bu, T. H. Lee, W. J. Jeong, M. J. Poellmann, K. Mudd, H. S. Eun, E. W. Liu, S. Hong and S. H. Hyun, PloS One, 15(12), e0242145 (2020).
H. Z. Kimbrell, A. B. Sholl, S. Ratnayaka, S. Japa, M. Lacey, G. Carpio, P. Bhatia and E. Kandil, BioMed. Res. Int., 2015, 486391 (2015).
C. Li, K. C. Lee, E. B. Schneider and M. A. Zeiger, J. Clin. Endocrinol. Metab., 97(12), 4559 (2012).
D. Jeong, Y. Jeong, J. H. Park, S. W. Han, S. Y. Kim, Y. J. Kim, S. J. Kim, Y. Hwangbo, S. Park, H. D. Cho, M. H. Oh, S. H. Yang and C. J. Kim, Ann. Surg. Oncol., 20(3), 759 (2013).
J. Bu, T. H. Lee, M. J. Poellmann, P. A. Rawding, W. J. Jeong, R. S. Hong, S. H. Hyun, H. S. Eun and S. Hong, Clin. Transl. Med., 11(8), e499 (2021).
M. Prpić, M. Franceschi, M. Romić, T. Jukić and Z. Kusić, Acta Clinica Croat., 57(3), 518 (2018).
B. S. H. Indrasena, World J. Biol. Chem., 8(1), 81 (2017).
C. K. Zhao, J. Y. Zheng, L. P. Sun, R. Y. Xu, Q. Wei and H. X. Xu, Cancer Med., 8(12), 5577 (2019).
Acknowledgement
This work was supported by Basic Science Research Program Funded by Ministry of Science and Technology (Republic of Korea) under grant # NRF-2022R1F1A1075414. It has been also partially supported by NRF under grant # NRF-2020R1A2C4001856/#NRF-2019M3E5D1A02068557, KHIDI under grant #HR20C0025040021, Chungnam National University Hospital Research Fund 2019, the Leaders in Industry-university Cooperation 3.0 Project, and the National Research Foundation of Korea Grant funded by the Korean Government(MOE).
Author information
Authors and Affiliations
Corresponding authors
Additional information
Conflict of Interest
The authors declare no conflict of interest.
Supporting Information
Additional information as noted in the text. This information is available via the Internet at http://www.springer.com/chemistry/journal/11814.
Electronic Supplementary Material
Rights and permissions
About this article
Cite this article
Lee, T.H., Jeon, H.J., Choi, J.H. et al. A high-sensitivity cfDNA capture enables to detect the BRAF V600E mutation in papillary thyroid carcinoma. Korean J. Chem. Eng. 40, 429–435 (2023). https://doi.org/10.1007/s11814-022-1348-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11814-022-1348-0